Heterogeneity of vascular smooth muscle α-adrenoceptors in canine blood vessels

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 10, 1999, Pages 822-823

  Kwan, David Chiu Yin ^a  

^a Health Science Center   (Canada)

Author keywords

1 adrenoceptor subtypes; Aorta; Dog; Mesenteric artery; Mesenteric vein; Saphenous vein

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; PRAZOSIN; RAUWOLSCINE; RECEPTOR SUBTYPE;

ANIMAL TISSUE; AORTA; BLOOD VESSEL; CONFERENCE PAPER; DOG; DRUG RECEPTOR BINDING; LIGAND BINDING; MESENTERIC ARTERY; MESENTERIC VEIN; NONHUMAN; RECEPTOR DENSITY; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD VESSELS; DOGS; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, ADRENERGIC, ALPHA;

EID: 0032879443     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03136.x     Document Type: Conference Paper

References (13)

1. 1. Kwan CY, Grarfield RE, Daniel EE. An improved procedure for the isolation of plasma membranes from mesenteric arteries. J. Mol. Cell. Cardiol. 1970; 11: 639-59.
2. 2. Kwan CY, Lee RMKW, Daniel EE. Isolation of plasma membranes from mesenteric veins: A comparison of their physical and biochemical properties with arterial membranes. Blood Vessels 1981; 18: 171-86.
3. 3. Kwan CY, Sipos SN, Osterroth A, Daniel EE. β-Adrenoreceptors in vascular muscle with special reference to subcellular localization and number of binding sites. J. Pharmacol. Exp. Ther. 1987; 243: 1074-81.
4. max) of α-adrenoceptor binding sites and contractile response in four canine vascular tissues. J. Pharmacol Exp. Ther. 1989; 250: 1119-24.
5. 5. Daniel EE, Shi AG, Wang ZL et al. α-Adrenoceptors in vascular smooth muscle: All is not well. Blood Vessels 1991; 28: 104-14.
6. 6. Hieble JP, Bylund DB, Clarke DE et al. Recommendation for nomenclature α1-adrenoceptors: Consensus update. Pharmacol. Rev. 1995; 47: 267-70.
7. 7. Daniel EE, Low AM, Gaspar V et al. Unusual α-adrenoceptor subtype in canine saphenous vein: Comparison to mesenteric vein. Br. J Pharmacol. 1996; 117: 1535-43.
8. 2-adrenoceptor subtypes in canine aorta using alkylating agents. Can. J. Physiol. Pharmacol. 1994; 72: 97-103.
9. 9. Low AM, Lu-Chao H, Wang YF, Brown RD, Kwan CY, Daniel EE. Pharmacological and immunochemical characterization of subtypes of α-I adrenoceptors in dog aorta. J. Pharmacol. Exp. Ther. 1997; 285: 894-901.
10. 10. Shimamoto H, Bourreau JP, Kwan CY, Daniel EE. Amplification of α-adrenergic vasoconstriction in canine isolated mesenteric artery and vein. J. Pharmacol. Exp. Ther. 1992; 260: 1119-27.
11. 11. Daniel EE, Low AM, Lu-Chao H, Gaspar V, Kwan CY. Characterization of a1-adrenoceptors in canine mesenteric vein. J. Cardiovasc. Pharmacol. 1997; 30: 591-8.
12. 12. Low AM, Bowdish DM, Prashad TR, Gaspar V. Interactions of chlorocthylclonidine with prazosin-and rauwolscine-sensitive adrenoceptors in dog saphenous vein. Br. J. Pharmacol. 1994; 113: 1263-8.
13. 13. Mo FM, Kwan CY. α-Adrenoceptor subtypes of dog saphenous vein: Another unusual property. Life Sci. 1998; 62: 1455-9.